These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 35156640

  • 1. Immunohistochemical Analysis Of Novel Biomarkers Cyclin D1, p53 And Ki67 In Endometrial Carcinoma: Clinicopathological Significance And Prognostic Value.
    Atram MA, Shivkumar VB, Gangane NM.
    Gulf J Oncolog; 2022 Jan; 1(38):15-23. PubMed ID: 35156640
    [Abstract] [Full Text] [Related]

  • 2. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters.
    Mitselou A, Ioachim E, Zagorianakou N, Kitsiou E, Vougiouklakis T, Agnantis NJ.
    Eur J Gynaecol Oncol; 2004 Jan; 25(6):719-24. PubMed ID: 15597850
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2001 Apr 01; 49(5):1305-10. PubMed ID: 11286838
    [Abstract] [Full Text] [Related]

  • 4. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
    Mielcarek-Kuchta D, Olofsson J, Golusinski W.
    Eur Arch Otorhinolaryngol; 2003 Nov 01; 260(10):549-54. PubMed ID: 14551784
    [Abstract] [Full Text] [Related]

  • 5. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN, Abdelrahman AS, Butt NS, Al-Maghrabi B, Al-Maghrabi J.
    Ann Diagn Pathol; 2017 Oct 01; 30():47-51. PubMed ID: 28965628
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I.
    Hum Pathol; 2003 May 01; 34(5):471-8. PubMed ID: 12792921
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M.
    J Oral Pathol Med; 2012 Jan 01; 41(1):40-6. PubMed ID: 21883486
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ, Montironi R.
    Eur Urol; 2004 May 01; 45(5):606-12. PubMed ID: 15082203
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 01; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 10. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY, Xu ZN, Wang JX, Wei DM, Pan XL.
    Asian Pac J Cancer Prev; 2012 Jan 01; 13(5):2133-7. PubMed ID: 22901182
    [Abstract] [Full Text] [Related]

  • 11. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN, Mirejovský P, Mirejovský T, Melínová L, Mandys V.
    Acta Histochem; 2000 Aug 01; 102(3):323-38. PubMed ID: 10990069
    [Abstract] [Full Text] [Related]

  • 12. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H.
    J Cancer Res Clin Oncol; 2004 Mar 01; 130(3):161-8. PubMed ID: 14689303
    [Abstract] [Full Text] [Related]

  • 13. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
    Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB.
    Int J Gynecol Pathol; 2004 Apr 01; 23(2):129-37. PubMed ID: 15084841
    [Abstract] [Full Text] [Related]

  • 14. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.
    Arch Med Res; 2007 Nov 01; 38(8):846-52. PubMed ID: 17923265
    [Abstract] [Full Text] [Related]

  • 15. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T, Miller E, Duska L, Oliva E.
    Am J Surg Pathol; 2012 May 01; 36(5):753-61. PubMed ID: 22498825
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
    Salvesen HB, Iversen OE, Akslen LA.
    J Clin Oncol; 1999 May 01; 17(5):1382-90. PubMed ID: 10334522
    [Abstract] [Full Text] [Related]

  • 17. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr 01; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 18. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
    Yurakh AO, Ramos D, Calabuig-Fariñas S, López-Guerrero JA, Rubio J, Solsona E, Romanenko AM, Vozianov AF, Pellin A, Llombart-Bosch A.
    Eur Urol; 2006 Sep 01; 50(3):506-15; discussion 515. PubMed ID: 16624482
    [Abstract] [Full Text] [Related]

  • 19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 20. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y, Watanabe G, Yamasaki S, Maeda M, Kawabe A, Kaganoi JI, Itami A, Fukumoto M, Kanda Y, Imamura M.
    Eur J Cancer; 2000 May 01; 36(8):987-93. PubMed ID: 10885602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.